Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

999 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Active, Not Recruiting

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

NCT03367741

Conditions
Advanced Endometrial Carcinoma, Carcinosarcoma, Endometrial Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

NCT07120945

Conditions
Adenomyosis, Adenomyosis of Uterus, Adnexal Diseases, +38 more
Locations
  • Ascension St. Vincent's Riverside Jacksonville, Florida, United States
  • The University of South Florida Tampa, Florida, United States
  • Duke University Durham, North Carolina, United States
  • Allegheny Health Network - West Penn Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

NCT04269200

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Concord, California, United States
  • Research Site La Jolla, California, United States
  • Research Site San Francisco, California, United States
View all 201 locations
View Trial Details
Active, Not Recruiting

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

NCT05611931

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Honor Health Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UC DAVIS Davis, California, United States
View all 204 locations
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details

Related conditions